YONGAN PHARMACEUTICAL(SZ:002365) Xin Lang Cai Jing·2025-10-15 03:42Core Viewpoint - Yong'an Pharmaceutical experienced a 5.13% increase in stock price, reaching 19.66 CNY per share, with a trading volume of 549 million CNY and a turnover rate of 11.74%, resulting in a total market capitalization of 5.793 billion CNY [1] Company Overview - Yong'an Pharmaceutical Co., Ltd. is located in Qianjiang Economic Development Zone, Hubei Province, and was established on June 18, 2001, with its listing date on March 5, 2010 [1] - The company primarily engages in the research, production, and sales of taurine products, with main business revenue composition being 64.14% from taurine and 35.86% from other products [1] Fund Holdings - According to data, Ping An Fund has a significant holding in Yong'an Pharmaceutical through the Ping An CSI 2000 Enhanced Strategy ETF (159556), which held 3,100 shares in the second quarter, accounting for 0.29% of the fund's net value, ranking as the fourth-largest holding [2] - The Ping An CSI 2000 Enhanced Strategy ETF (159556) was established on December 27, 2023, with a latest scale of 28.7267 million CNY, and has achieved a year-to-date return of 25.42%, ranking 1928 out of 4220 in its category [2] - The fund manager, Yu Yao, has a tenure of 3 years and 347 days, with a total asset scale of 131 million CNY, achieving a best return of 17.23% and a worst return of -20.06% during the tenure [2]